Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Carson, André [D-IN-7]

Rep. Carson, André [D-IN-7]

United States · Official source

Records

6,543 records where Rep. Carson, André [D-IN-7] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 6835 (119th)open

Veterans STAND Act

United States · United States Congress · 18 December 2025

Bill· HRH.R. 6786 (119th)referred

Schedules That Work Act

United States · United States Congress · 17 December 2025

Bill· HRH.R. 6766 (119th)referred

Essential Caregivers Act of 2025

United States · United States Congress · 16 December 2025

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.

Bill· HRH.R. 6758 (119th)referred

UPLIFT Act

United States · United States Congress · 16 December 2025

Bill· HRH.R. 6686 (119th)referred

No Cost Educational Resources Act of 2025

United States · United States Congress · 12 December 2025

No Cost Educational Resources Act of 2025 This bill authorizes the Institute of Museum and Library Services to award grants to institutions of higher education (IHEs) for facilitating the adoption, adaption, and creation of open educational reading materials and establishing more open educational reading material courses. Open educational reading material refers to a free digital text that is publicly available to be downloaded and redistributed. Open educational reading material course refers to a science, technology, engineering, or math course offered by an IHE that uses only open educational reading materials as the form of the required readings for the course.

Bill· HRH.R. 6658 (119th)referred

BASIC Act

United States · United States Congress · 11 December 2025

Bill· HRH.R. 6565 (119th)referred

Reuniting Families Act

United States · United States Congress · 10 December 2025

Resolution· HRESH.Res. 939 (119th)passed

Impeaching Donald John Trump, President of the United States for high crimes and misdemeanors.

United States · United States Congress · 10 December 2025

This resolution sets forth two articles of impeachment against President Donald Trump for high crimes and misdemeanors on charges of (1) abuse of presidential power by calling for the execution of Members of Congress, and (2) abuse of presidential power to intimidate federal judges in violation of the separation of powers and independence of the judiciary.

Bill· HRH.R. 6509 (119th)referred

SAFE Drugs Act of 2025

United States · United States Congress · 9 December 2025

Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025 or the SAFE Drugs Act of 2025 This bill provides for increased oversight of drug compounding and imposes statutory limits on compounded drugs that are essentially copies of commercially available drugs. Currently, subject to certain requirements, compounded drugs (i.e., drugs that are mixed or altered to meet patient needs) do not require Food and Drug Administration (FDA) approval. Additional limits apply to the compounding of drugs that are essentially copies of commercially available drug products. Under the bill, a compounded drug is essentially a copy of a commercially available drug product if (1) the compounded drug contains any active ingredient found in a commercially available drug product, and (2) there is no change made for an individual patient that results in a significant difference between the compounded drug and the commercially available drug. (The FDA’s current definition of the term also addresses dosage strength and route of administration.)  The bill increases the frequency at which a licensed pharmacist or physician may compound a drug that is essentially a copy of a commercially available drug to 20 times per month. Current FDA policy allows four such prescriptions per month. The bill also imposes annual reporting requirements on physicians, facilities, and pharmacies (except hospital-based pharmacies) that compound certain drug products for out-of-state patients more than 20 times per month. Further, the bill subjects certain large-scale outsourcing facilities (i.e., FDA-registered facilities that compound in bulk) to regular inspection and reporting requirements.

Bill· HRH.R. 6469 (119th)referred

FREEDOM Act

United States · United States Congress · 4 December 2025

Bill· HRH.R. 6461 (119th)reported

READ AI Models Act

United States · United States Congress · 4 December 2025

Resources for Evaluating and Documenting AI Models or the READ AI Models Act This bill requires the National Institute of Standards and Technology (NIST) to develop a customizable template for information to accompany artificial intelligence (AI) models. Specifically, NIST must initiate a pilot program to establish a structured template that may be used to document information about an artificial intelligence model and any associated data, such as the model’s name, the developer, and the cutoff date for the model’s training data. The template must be modular to enable users to adopt and complete various sections to suit their needs and intended audience. NIST must also provide technical guidelines to accompany the template that incorporate consensus-based standards and industry best practices, as appropriate. In developing these materials, NIST must collaborate with and conduct periodic outreach to various stakeholders, including private sector entities, international standards organizations, and institutions of higher education. NIST must publish and solicit public comment on a draft of the template and guidelines. Within 12 months of the start of the pilot program, NIST must publish the finished products and report to Congress with an assessment of the program.

Bill· HRH.R. 6371 (119th)referred

No Robot Bosses Act

United States · United States Congress · 3 December 2025